Phase 1 Open-Label Pilot Trial of H4 dTMS for Cannabis Use Disorder
Deep repetitive transcranial magnetic stimulation cannabis use is being studied as a novel intervention for cannabis use disorder. This phase 1 open-label pilot trial evaluates safety and feasibility. The study targets adults with moderate-to-severe…
The Effects of Extended Cannabis Abstinence in Comorbid PTSD and Cannabis Use Disorder
This study investigates cannabis cessation PTSD dual diagnosis outcomes in patients with comorbid cannabis use disorder and PTSD. Extended cannabis abstinence resolves withdrawal symptoms but PTSD symptoms often persist. Understanding these effects…
Cannabinoids Show Modest, Low-Certainty Benefits for a Few Mental Health Conditions—But Widespread Clinical Use Is Not Justified
This 2026 review examines cannabinoids mental health benefits, revealing modest effects for select conditions. Evidence remains limited and of low certainty. Routine clinical use is not justified without further trials.
People with Cannabis Disorder Show Unique Neurobiology and Attention Patterns
Cannabis use disorder neurobiology reveals distinct brain pathways compared to other addictions. Individuals with this disorder do not show increased attention to cannabis-related images. This suggests unique cognitive mechanisms in cannabis use disorder.
Benzie County Sees 24% Increase in Marijuana Excise Tax Revenue
Local marijuana excise tax revenue in Benzie County jumped by 24%, signaling significant growth in the cannabis market. This increase reflects expanding patient access and market normalization. Clinicians should note this trend as it impacts patient…
Cannabis Hyperemesis Syndrome: A Psychiatric Approach
Cannabis hyperemesis syndrome psychiatric risk is a critical consideration in patients with chronic cannabis use presenting with cyclical vomiting. This syndrome often poses diagnostic challenges in psychiatric settings due to overlapping symptoms. Early…
Comprehensive Review Reveals Cannabis Use Disorder Affects 10% of World’s 193 Million Cannabis Users
Cannabis use disorder epidemiology shows it affects about 10% of cannabis users worldwide. Risk increases with frequency of use and early initiation. Psychosocial treatments exist but no approved medications are available.
Cannabinoid Clinical Trials: Cannabis Interventions for Teens
Cannabis interventions for teens require tailored approaches to address diverse beliefs and attitudes. Clinical trials show that personalized messaging can reduce cannabis use intentions among adolescents. This research highlights the importance of…
Comparing Psychiatric Outcomes in Cannabis Use Disorder and Other Substance Disorders
This article examines psychiatric outcomes cannabis use disorder comparison with other substance use disorders. Understanding these differences aids clinicians in screening and counseling patients effectively. The focus on real-world data highlights the…
Endocannabinoid System & Teen Mental Health: Clinical Evidence
Adolescents with internalising symptoms are at increased risk for cannabis use. This study highlights the internalising pathway cannabis use adolescents face. Anxiety and depression symptoms predict cannabis initiation.